Seidel D	2498
Validated detection of human anti-chimeric immune responses in serum of neuroblastoma patients treated with ch14.18/CHO.
Functional bioassays for immune monitoring of high-risk neuroblastoma patients treated with ch14.18/CHO anti-GD2 antibody.
Disialoganglioside-specific human natural killer cells are effective against drug-resistant neuroblastoma